abstract |
The present invention provides materials and methods for determining the optimal dosage regimen for a therapeutic agent. In particular, the invention relates to dosage regimens for therapeutic agents that can target the IL-2 receptor, preferably interleukin 2 (IL2) based therapeutic agents. The method of the present invention allows the determination of a general dosage regimen for new IL-2R targeted therapeutic agents, but is also treated with therapeutic agents targeting IL-2R It also makes it possible to obtain specially tailored dosage regimens for individuals. |